Provera 250 mg tabl.
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Medroxyprogesterone Acetate 250 mg
Available from:
Pfizer SA-NV
ATC code:
G03DA02
INN (International Name):
Medroxyprogesterone Acetate
Dosage:
250 mg
Pharmaceutical form:
Tablet
Composition:
Medroxyprogesterone Acetate 250 mg
Administration route:
Oral use
Therapeutic area:
Medroxyprogesterone
Product summary:
CTI code: 130654-02 - Pack size: 50 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 130654-01 - Pack size: 40 - Commercialisation status: YES - FMD code: 05415062313572 - CNK code: 0839100 - Delivery mode: Medical prescription
Authorization status:
Commercialised: Yes
Authorization date:
1985-02-14
